PharmTech News

Articles

The company said it has plans to address global health challenges including vaccines, antimicrobial resistance, and preparation for future pandemics.

GSK Announces Plans to Address Emerging Global Health Issues

Walmsley will succeed Andrew Witty as CEO of the British drug maker.

GSK Appoints Emma Walmsley CEO

Caroline Hroncich was associate editor for Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International from 2015 to 2017.

On Sept. 19, 2016, FDA announced that it has granted accelerated approval to Exondys 51 (eteplirsen), an injection for the treatment of Duchenne muscular dystrophy (DMD). The drug is marketed by Sarepta Therapeutics in the United States and is currently the only approved treatment for DMD. In light of the approval, Sarepta shares catapulted 76%, Seeking Alpha reported.

FDA Approves First Drug for Duchenne Muscular Dystrophy

Adaptimmune entered into a manufacturing agreement with PCT for the manufacture of its SPEAR T-cell therapies.

Adaptimmune Enters into Manufacturing Agreement with PCT

The autoinjector is based on core technology licensed from Bespak.

UCB Receives Positive EU CHMP Opinion for Cimzia AutoClicks Prefilled Pen

Bayer will acquire the agricultural company for $66 billion in an all cash transaction.

Bayer Acquires Monsanto

The project aims to address challenges facing the development, manufacture, and delivery of vaccines.

Merck KGaA Joins the DiViNe Project

Allergan will acquire Vitae pharmaceuticals for $639 million.

Allergan to Acquire Vitae Pharmaceuticals

The company voluntarily recalled the product due to detached needles on the syringe in the kit.

Novo Nordisk Recalls GlucaGen HypoKit

Horizon Pharma will acquire Raptor Pharmaceuticals with the transaction expected to close in the fourth quarter of 2016.

Bio/Pharma News